Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Ophthalmology
    • New Drug Research...

    New Drug Research Could Prevent Secondary Cataract

    Written by supriya kashyap kashyap Published On 2016-04-29T14:47:30+05:30  |  Updated On 29 April 2016 2:47 PM IST
    New Drug Research Could Prevent Secondary Cataract

    Scientists at the University of East Anglia may have found a way to prevent complications from surgery to treat cataract the world’s leading cause of blindness.


    It’s estimated that by the year 2020, 32 million people will need cataract surgery. Cataracts develop as people age, and the eye’s lens turns from clear to cloudy.


    Surgery works well to restore vision. Natural lens cells are removed from the inside of the lens, which leaves an outer casing called the ‘capsular bag’ that can house a clear, artificial lens. The capsular bag effectively ‘shrink-wraps’ the new lens and holds it in place.


    However, a few natural lens cells always remain after surgery. In time the eye’s wound-healing response leads the cells to spread across the underside of the artificial lens. This interferes with vision, causing what’s known as ‘posterior capsule opacification’ or secondary cataract.


    Dr Michael Wormstone, from UEA’s School of Biological Sciences, who led the study, said: “Secondary visual loss responds well to treatment with laser surgery. But as life-expectancy increases, the problems of cataract and posterior capsule opacification will become even greater in terms of both patient well-being and economic burden. It’s essential that we find better ways to manage the condition in future.”


    Newer artificial lenses are being designed to be placed into a capsular bag that stays open, instead of shrink-wrapping closed. The thinking is that if fluid in the eye (aqueous humour) can flow around the artificial lens, it will dilute and wash away the cell-signalling molecules that encourage re-growth.


    In this study, the researchers took a two-pronged approach, using human cells and tissue. They first tested the idea that diluting growth factor can prevent cells invading the posterior capsule. They also aimed to understand more about which growth factors drive the process with a view to developing a future drug treatment.


    Dr Wormstone said: “Our results show that reducing the amount of growth factor that’s available around the intraocular lens significantly impedes cell invasion and adds to the evidence in favour of open-bag cataract surgery.


    “Moreover, we found that vascular endothelial growth factor (VEGF) plays an important role in cell growth and survival. Therefore we believe that anti-VEGF treatment is a logical target for new drug treatments that could help enhance the effect of better lens design and placement, to prevent secondary cataract.”


    Human capsular bags bathed in VEGF inhibitor meant significantly fewer cells invaded the posterior capsule. This pattern was also observed when the fluid volume was increased. On the left, untreated, on the right, VEGF inhibitor. From Eldred et al 2016.


    The study was part-funded by eye research charity Fight for Sight.


    Dr Dolores M Conroy, Fight for Sight’s director of research, said: “These are encouraging results, with research to develop new intraocular lenses that incorporate anti-VEGF treatment into their design as a potential next step.


    “Whether this will work depends on many factors including the safety of anti-VEGF treatment in this part of the eye. However its current use as a treatment to block new blood vessel growth in the wet form of age-related macular degeneration means there is already a body of research from which we can perhaps draw useful insights.


    “Reducing the need for secondary cataract surgery is a highly important goal and indeed, preventing PCO was identified as a high priority by patients in the Sight Loss and Vision Priority Setting Partnership a consultation to set priorities for eye research.”


    Follow-up work from the group will be presented at the Association for Research in Vision and Ophthalmology annual meeting (ARVO 2016) which takes place in Seattle from May 1-5.


    ‘Growth factor restriction impedes progression of wound healing following cataract surgery: identification of VEGF as a putative therapeutic target’ is published in the journal Scientific Reports.

    capsular bagcataract surgeryDr Dolores M ConroyDr Michael Wormstonedrug researchSchool of Biological SciencesUniversity of East Angliavascular endothelial growth factorVEGF
    Source : ScienceDaily

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok